Joseph Pultz

652 total citations
11 papers, 526 citations indexed

About

Joseph Pultz is a scholar working on Psychiatry and Mental health, Clinical Psychology and Social Psychology. According to data from OpenAlex, Joseph Pultz has authored 11 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 3 papers in Clinical Psychology and 2 papers in Social Psychology. Recurrent topics in Joseph Pultz's work include Schizophrenia research and treatment (8 papers), Electroconvulsive Therapy Studies (2 papers) and Child and Adolescent Psychosocial and Emotional Development (2 papers). Joseph Pultz is often cited by papers focused on Schizophrenia research and treatment (8 papers), Electroconvulsive Therapy Studies (2 papers) and Child and Adolescent Psychosocial and Emotional Development (2 papers). Joseph Pultz collaborates with scholars based in United States and Germany. Joseph Pultz's co-authors include Elyse Stock, Vladimir Coric, Anne L. Hoff, John W. Newcomer, Roderick K. Mahurin, Dawn I. Velligan, John G. Csernansky, Alexander L. Miller, Ronald N. Marcus and Louis F. Fabre and has published in prestigious journals such as Schizophrenia Research, The Journal of Clinical Psychiatry and Journal of Neuroimmunology.

In The Last Decade

Joseph Pultz

11 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Pultz United States 8 296 115 88 85 82 11 526
J. Hatzimanolis Greece 14 298 1.0× 66 0.6× 76 0.9× 58 0.7× 83 1.0× 41 527
Enrico Zanalda Italy 11 140 0.5× 166 1.4× 78 0.9× 110 1.3× 45 0.5× 20 467
Adelheid Czernik Germany 11 411 1.4× 141 1.2× 103 1.2× 97 1.1× 136 1.7× 30 747
Kelly Schwartz United States 8 324 1.1× 74 0.6× 124 1.4× 172 2.0× 80 1.0× 8 674
A F Schatzberg United States 12 285 1.0× 115 1.0× 75 0.9× 176 2.1× 126 1.5× 15 625
Thomas Stamm Germany 17 364 1.2× 140 1.2× 63 0.7× 179 2.1× 49 0.6× 42 698
Gabriella Rapini Italy 14 306 1.0× 231 2.0× 46 0.5× 106 1.2× 43 0.5× 19 627
Cengiz Akkaya Türkiye 14 300 1.0× 135 1.2× 29 0.3× 66 0.8× 75 0.9× 62 592
Angela M. Henricks United States 8 204 0.7× 63 0.5× 154 1.8× 115 1.4× 41 0.5× 18 488
Karen O’Flynn Ireland 9 124 0.4× 136 1.2× 125 1.4× 44 0.5× 43 0.5× 10 356

Countries citing papers authored by Joseph Pultz

Since Specialization
Citations

This map shows the geographic impact of Joseph Pultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Pultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Pultz more than expected).

Fields of papers citing papers by Joseph Pultz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Pultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Pultz. The network helps show where Joseph Pultz may publish in the future.

Co-authorship network of co-authors of Joseph Pultz

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Pultz. A scholar is included among the top collaborators of Joseph Pultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Pultz. Joseph Pultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Coric, Vladimir, Howard Feldman, Dan A. Oren, et al.. (2010). Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depression and Anxiety. 27(5). 417–425. 136 indexed citations
2.
Coric, Vladimir, Elyse Stock, Joseph Pultz, Ronald N. Marcus, & David V. Sheehan. (2009). Sheehan Suicidality Tracking Scale (Sheehan-STS): Preliminary Results from a Multicenter Clinical Trial in Generalized Anxiety Disorder.. PubMed. 6(1). 26–31. 71 indexed citations
3.
Perlis, Roy H., B. D. Gaulin, Rolando Gutierrez-Esteinou, et al.. (2007). Antimanic Response to Aripiprazole in Bipolar I Disorder Patients Is Independent of the Agitation Level at Baseline. The Journal of Clinical Psychiatry. 68(9). 1377–1383. 19 indexed citations
4.
Marder, Stephen R., et al.. (2007). Aripiprazole Effects in Patients With Acute Schizophrenia Experiencing Higher or Lower Agitation. The Journal of Clinical Psychiatry. 68(5). 662–668. 20 indexed citations
5.
Velligan, Dawn I., John W. Newcomer, Joseph Pultz, et al.. (2002). Does cognitive function improve with quetiapine in comparison to haloperidol?. Schizophrenia Research. 53(3). 239–248. 154 indexed citations
6.
Velligan, Dawn I., John W. Newcomer, Joseph Pultz, et al.. (2000). Improvement in cognitive functioning with long-term quetiapine is superior to haloperidol. Schizophrenia Research. 41(1). 205–205. 2 indexed citations
7.
Vinogradov, Sophia, Carl Salzman, Joseph Pultz, & Paul Yeung. (2000). Long-term safety, tolerability and clinical improvement with quetiapine in elderly patients with schizophrenia. Schizophrenia Research. 41(1). 207–207. 2 indexed citations
8.
Glazer, William M., Hal Morgenstern, Joseph Pultz, Paul Yeung, & Ihor W Rak. (2000). Incidence of tardive dyskinesia is lower with quetiapine treatment than with typical antipsychotics in patients with schizophrenia and schizoaffective disorder. Schizophrenia Research. 41(1). 206–207. 8 indexed citations
9.
Tariot, Pierre N., Carl Salzman, Paul Yeung, Joseph Pultz, & Jill M. Goldstein. (1999). Clinical Improvement and tolerability is maintained long term in elderly patients with psychotic disorders treated with quetiapine. European Neuropsychopharmacology. 9. 268–268. 3 indexed citations
10.
Fabre, Louis F., et al.. (1995). ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia. Clinical Therapeutics. 17(3). 366–378. 84 indexed citations
11.
Liu, Yuhong, Ben B. Whitlock, Joseph Pultz, & Seth A. Wolfe. (1995). Sigma-1 receptors modulate functional activity of rat splenocytes. Journal of Neuroimmunology. 59(1-2). 143–154. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026